Search Results: Displaying all items (111)

First Author Title Journal Publication Date
Khawcharoenporn T. QuantiFERON(®)-TB Gold In-tube Test for tuberculosis prevention in HIV-infected patients. Japanese journal of infectious diseases 2017
Dai Q. Influential Factors of the Indeterminate Results Tested by QuantiFERON-TB Gold In-Tube (QFT-IT) Assay for Diagnosing TB Infection in HIV-Infected Patients. Clinical laboratory 2016
LaCourse SM. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting. Journal of acquired immune deficiency syndromes (1999) 2017
Xin HN. Tuberculosis infection testing in HIV-positive men who have sex with men from Xi'an China. Epidemiology and infection 2016
Dai Q. QFT-IT for diagnosing and screening TB infection in HIV patients: CD4 cells count as an important influential factor. International journal of STD & AIDS 2016
Leung CC. Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong. Respirology (Carlton, Vic.) 2016
Mathad JS. Quantitative IFN-γ,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women. American journal of respiratory and critical care medicine 2016
Kumarasamy N. A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Medicine 2016
Danel C. Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa. PloS one 2014
Rose W. Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values. BMC infectious diseases 2014
Sauzullo I. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response. The new microbiologica 2014
Lyne K. Diagnosis of latent tuberculosis infection among HIV-infected clients in Far North Queensland: use of an interferon-gamma release assay. Sexual health 2013
Stout JE. Integrated Screening for Tuberculosis and HIV in Tuberculosis Contact Investigations: Lessons Learned in North Carolina. Public health reports (Washington, D.C. : 1974) 2014
Rüütel K. Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. The International journal on drug policy 2013
Doyle JS. Latent tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile? Journal of acquired immune deficiency syndromes (1999) 2014
Pullar ND. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2014
Chkhartishvili N. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia. BMC infectious diseases 2013
Lagrange PH. A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multicentric Study (2006-2008). Evaluation of QuantiFERON-TB Gold in Tube for TB Diagnosis. PloS one 2013
Kowada A. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries. The Journal of infection 2013
Sultan B. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults. International journal of STD & AIDS 2013
Load More Results